Phio Pharmaceuticals Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Phio Pharmaceuticals Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Phio Pharmaceuticals Corp. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 -$66K -100% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $0 -$98K -100% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $0 -$130K -100% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $33K -$128K -79.5% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $66K -$126K -65.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $98K -$125K -56.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $130K -$123K -48.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $161K -$122K -43.1% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $192K -$121K -38.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $223K -$119K -34.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $253K -$118K -31.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $283K -$117K -29.3% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $313K -$115K -26.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $342K -$114K -25% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $371K -$113K -23.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $400K -$111K -21.7% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $428K -$110K -20.4% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $456K -$109K -19.3% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $484K -$108K -18.2% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $511K +$511K Dec 31, 2019 10-K 2021-03-25
Q3 2019 $538K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $565K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $592K Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.